Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 32
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Telemed J E Health ; 19(4): 265-71, 2013 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-23540276

RESUMO

OBJECTIVE: Rapid on-site evaluation (ROSE) at the time of endobronchial ultrasound-guided transbronchial fine needle aspiration (EBUS-TBFNA) is useful in obtaining adequate samples and providing preliminary diagnosis. We present our experience with ROSE of EBUS-TBFNA using telecytopathology. MATERIALS AND METHODS: Real-time images of Diff-Quik (Mercedes Medical, Sarasota, FL)-stained cytology smears were obtained with an Olympus (Olympus America, Center Valley, PA) digital camera attached to an Olympus CX41 microscope and transmitted via ethernet by a cytotechnologist to a cytopathologist in a cytopathology laboratory who rendered a preliminary diagnosis while communicating with an on-site cytotechnologist via the Vocera (San Jose, CA) voice communication system. The endoscopy suite was located a block away from the cytopathology laboratory. Accuracy of ROSE via telecytopathology was compared with an equal number of cases that received ROSE, prior to introduction of telecytopathology, via conventional microscopy. RESULTS: ROSE was performed on a total of 200 EBUS-TBFNAs. The telecytopathology system and conventional microscopy were used to evaluate equal numbers of cases (100 each). Preliminary diagnoses of negative/benign, atypical/suspicious, and positive for malignancy were 58%, 14%, and 24% for telecytopathology and 57%, 10%, and 31% for conventional microscopy. Four percent of telecytopathology cases and 2% of conventional microscopy cases were deemed unsatisfactory at the time of ROSE. The overall concordance between the preliminary and final diagnoses was 96% for telecytopathology and 93% for conventional microscopy. The causes of discordant preliminary and final diagnoses could be mainly attributed to difficulty in distinguishing small cell carcinoma versus reactive lymph node due to crush artifact, atypia related to reactive bronchial epithelial cells, and availability of cell block material and Papanicolaou-stained slides for review at the time of final cytologic sign out. CONCLUSIONS: Telecytopathology is comparable with conventional microscopy in ROSE of EBUS-TBFNA. It can serve as a valid substitute for conventional microscopy for on-site assessment of EBUS-TBFNA.


Assuntos
Neoplasias Pulmonares/diagnóstico , Neoplasias Pulmonares/patologia , Pulmão/diagnóstico por imagem , Telepatologia/métodos , Biópsia por Agulha Fina , Humanos , Ultrassonografia de Intervenção
2.
CMAJ ; 179(4): 338-40, 2008 Aug 12.
Artigo em Inglês | MEDLINE | ID: mdl-18695182

RESUMO

Pulmonary lymphangitic carcinomatosis is a metastatic lung disease characterized by diffuse spread of the tumour to the pulmonary lymphatic system. We describe the case of a 31-year-old woman who initially received a diagnosis of sarcoidosis based on the results of imaging studies. However, results of a transbronchial biopsy led to the diagnosis of pulmonary lymphangitic carcinomatosis from metastatic colon cancer.


Assuntos
Neoplasias Pulmonares/diagnóstico , Sarcoidose/diagnóstico , Adulto , Neoplasias do Colo/patologia , Erros de Diagnóstico , Evolução Fatal , Feminino , Humanos , Neoplasias Pulmonares/fisiopatologia , Neoplasias Pulmonares/secundário , Tomografia Computadorizada por Raios X
3.
South Med J ; 101(7): 744-7, 2008 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-18580733

RESUMO

Immunosuppressive drugs used post-transplantation are among the most common causes of thrombotic thrombocytopenic purpura (TTP). Diagnosis is often confounded not only by its myriad presentations, but also because these manifestations may be explained by the comorbidities or complications of transplantation. A 61-year-old female who had a single lung transplant for severe chronic obstructive pulmonary disease maintained on corticosteroids, tacrolimus and mycophenolate mofetil, was admitted for fever, headache with confusion and lethargy. She was mildly anemic and thrombocytopenic. Peripheral smear showed rare fragmented red cells. Muddy brown casts were present on urinalysis. She was diagnosed with TTP. Tacrolimus was discontinued and the mental status of the patient, anemia and thrombocytopenia improved significantly.


Assuntos
Imunossupressores/efeitos adversos , Púrpura Trombocitopênica Trombótica/induzido quimicamente , Púrpura Trombocitopênica Trombótica/diagnóstico , Tacrolimo/efeitos adversos , Anemia Hemolítica/induzido quimicamente , Feminino , Humanos , Transplante de Pulmão/efeitos adversos , Pessoa de Meia-Idade , Púrpura Trombocitopênica Trombótica/patologia , Urinálise
5.
Indian J Chest Dis Allied Sci ; 49(1): 53-5, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17256569

RESUMO

Antiphospholipid antibody syndrome, also known as Hughes syndrome, is a hypercoagulable disorder that increases the risk of recurrent vascular thrombosis. We present a case of 26-year-old female who developed massive bilateral pulmonary emboli after being started on oral contraceptive pills. Further work-up of the patient revealed that she had anticardiolipin antibody syndrome and the thrombotic event was precipitated by oral contraceptive pills.


Assuntos
Síndrome Antifosfolipídica/complicações , Embolia Pulmonar/etiologia , Adulto , Feminino , Humanos
6.
J Comp Neurol ; 483(2): 154-63, 2005 Mar 07.
Artigo em Inglês | MEDLINE | ID: mdl-15678478

RESUMO

The birth and differentiation of neurons have been extensively studied in the olfactory epithelium (OE) of rodents but not in humans. The goal of this study was to characterize cellular composition and molecular expression of human OE in vivo and in vitro. In rodent OE, there are horizontal basal cells and globose basal cells that are morphologically and functionally distinct. In human OE, however, there appears to be no morphological distinction among basal cells, with almost all cells having round cell bodies similar to rodent globose basal cells. Unlike the case in rodents, human basal cells, including putative neuronal precursors, express p75NGFR, suggesting a distinctive role for p75NGFR in human OE neurogenesis. Molecular expression of neuronal cells during differentiation in human OE grossly follows that in rodents. However, the topographical organization of immature and mature ORNs in human OE differs from that of rodents, in that immature and mature ORNs in humans are dispersed throughout the OE, whereas rodent counterparts have a highly laminar organization. These observations together suggest that the birth and differentiation of neuronal cells in human OE differ from those in rodents. In OE explant culture, neuronal cells derived from human OE biopsy express markers for immature and mature neurons, grossly recapitulating neuronal differentiation of olfactory neurons in vivo. Furthermore, small numbers of cells are doubly label for bromodeoxyuridine and olfactory marker protein, indicating that neuronal cells born in vitro reach maturity. These data highlight species-related differences in OE development and demonstrate the utility of explant culture for experimental studies of human neuronal development.


Assuntos
Diferenciação Celular/fisiologia , Neurônios/metabolismo , Mucosa Olfatória/metabolismo , Células-Tronco/metabolismo , Adulto , Idoso , Idoso de 80 Anos ou mais , Envelhecimento/fisiologia , Antígenos de Diferenciação/biossíntese , Bromodesoxiuridina , Proliferação de Células , Forma Celular/fisiologia , Células Cultivadas , Humanos , Imuno-Histoquímica , Pessoa de Meia-Idade , Proteínas do Tecido Nervoso/biossíntese , Neurônios/citologia , Proteína de Marcador Olfatório , Mucosa Olfatória/citologia , Receptor de Fator de Crescimento Neural , Receptores de Fator de Crescimento Neural/biossíntese , Células-Tronco/citologia
7.
Neuropsychopharmacology ; 26(6): 817-23, 2002 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12007752

RESUMO

Non-adherence with medication remains a major correctable cause for poor outcome in schizophrenia. We describe a surgically implantable preparation of haloperidol with the aim that patients will have superior outcomes with improved medication adherence from implants. In contrast to depot formulations, implantable pellets could last many months, providing symptomatic improvement for periods of time never before possible. Additionally, in the event of unacceptable side effects, implants could be removed, offering a degree of reversibility not available with depot formulations. A surgically-implantable formulation of haloperidol has been created using biodegradable polymers. Implants have been characterized for in-vitro kinetics, as well as in-vivo bioactivity in rodents. Haloperidol implants demonstrate steady release of drug for 5 months. Animals treated with haloperidol implants display increased striatal D2 receptor expression as well as increased apomorphine stimulated locomotion. Surgically-implantable formulations are a viable approach to provide long-term delivery of antipsychotic medications to patients with psychotic disorders.


Assuntos
Antipsicóticos/administração & dosagem , Cateteres de Demora , Sistemas de Liberação de Medicamentos/métodos , Esquizofrenia/tratamento farmacológico , Animais , Cateteres de Demora/estatística & dados numéricos , Corpo Estriado/efeitos dos fármacos , Corpo Estriado/metabolismo , Preparações de Ação Retardada/administração & dosagem , Sistemas de Liberação de Medicamentos/estatística & dados numéricos , Haloperidol/administração & dosagem , Camundongos , Camundongos Endogâmicos C57BL , Atividade Motora/efeitos dos fármacos , Atividade Motora/fisiologia , Polietilenoglicóis/administração & dosagem , Poliglactina 910/administração & dosagem , Ratos , Ratos Sprague-Dawley , Receptores de Dopamina D2/biossíntese
8.
Neuropsychopharmacology ; 28(4): 675-82, 2003 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-12655312

RESUMO

People with schizophrenia exhibit impaired ability to modify electroencephalographic event-related potential (ERP) responses to novel stimuli. These deficits serve as a window into the abnormalities of neuronal organization and function and are thought to reflect a component of genetic vulnerability for schizophrenia. We describe differences among inbred mouse strains for ERPs following a novelty detection paradigm, as a model for genetic contributions to disease vulnerability. Auditory-evoked potentials were recorded during an auditory oddball task in nonanesthetized C57BL/6J, C3H/HeJ, and DBA/2J mice prior to and following ketamine (10 mg/kg). Stimuli consisted of 80 sets of 24 standard tones followed by one novel tone. Principal component analysis yielded four temporal components that contribute to the auditory ERP responses to standard and novel stimuli. Two principal components that varied between standard and novel stimuli also differed among inbred mouse strains. Post hoc analyses indicate that strain effects on novelty detection are due to a significant difference between the response to novel and standard tones in C3H/HeJ mice that is absent in the other two strains. Inbred strains of mice vary in their ability to perform neuronal detection of change in the auditory environment. The ability to model novelty detection deficits in mice will aid in identifying genetic contributions to abnormal neuronal organization in people with schizophrenia.


Assuntos
Potenciais Evocados Auditivos/fisiologia , Comportamento Exploratório/fisiologia , Receptores de N-Metil-D-Aspartato/antagonistas & inibidores , Estimulação Acústica/métodos , Animais , Potenciais Evocados Auditivos/efeitos dos fármacos , Comportamento Exploratório/efeitos dos fármacos , Camundongos , Camundongos Endogâmicos C3H , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos DBA , Receptores de N-Metil-D-Aspartato/fisiologia , Especificidade da Espécie
9.
Neuropsychopharmacology ; 29(4): 739-46, 2004 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-14735128

RESUMO

Auditory evoked potentials have been used in a variety of animal models to assess information-processing impairments in schizophrenia. Previous mouse models have primarily employed a paired click paradigm to assess the transient measures of auditory gating. The current study uses stimulus trains at varied interstimulus intervals (ISI) between 0.25 and 8 s in mice to assess the effects of chronic olanzapine and haloperidol on auditory processing. Data indicate that olanzapine increases the amplitude of the N40, P80, and P20/N40 components of the auditory evoked potential, whereas haloperidol had no such effect. The ISI paradigm also allowed for an evaluation of several components of the mouse evoked potential to assess those that display response properties similar to the human P50 and N100. Data suggest that the mouse N40 displays an ISI response relationship that shares characteristics with the human N100, whereas the P20 appears more consistent with the human P50 across the ISI range evaluated in this task. This study suggests that olanzapine may help improve N100 impairments seen in schizophrenia, while haloperidol does not.


Assuntos
Benzodiazepinas/farmacologia , Antagonistas de Dopamina/farmacologia , Potenciais Evocados Auditivos/efeitos dos fármacos , Haloperidol/farmacologia , Inibidores Seletivos de Recaptação de Serotonina/farmacologia , Estimulação Acústica/métodos , Análise de Variância , Animais , Relação Dose-Resposta a Droga , Eletroencefalografia/métodos , Potenciais Evocados Auditivos/efeitos da radiação , Camundongos , Camundongos Endogâmicos C57BL , Olanzapina , Fatores de Tempo
10.
Am J Med Genet ; 114(4): 391-406, 2002 May 08.
Artigo em Inglês | MEDLINE | ID: mdl-11992561

RESUMO

The search for genes in bipolar disorder has provided numerous genetic loci that have been linked to susceptibility to developing the disorder. However, because of the genetic heterogeneity inherent in bipolar disorder, additional strategies may need to be employed to fully dissect the genetic underpinnings. One such strategy involves reducing complex behaviors into their component parts (endophenotypes). Abnormal neurophysiological, biochemical, endocrinological, neuroanatomical, cognitive, and neuropsychological findings are characteristics that often accompany psychiatric illness. It is possible that some of these may eventually be useful in subdefining complex genetic disorders, allowing for improvements in diagnostic assessment, genetic linkage studies, and development of animal models. Findings in patients with bipolar disorder that may eventually be useful as endophenotypes include abnormal regulation of circadian rhythms (the sleep/wake cycle, hormonal rhythms, etc.), response to sleep deprivation, P300 event-related potentials, behavioral responses to psychostimulants and other medications, response to cholinergics, increase in white matter hyperintensities (WHIs), and biochemical observations in peripheral mononuclear cells. Targeting circadian rhythm abnormalities may be a particularly useful strategy because circadian cycles appear to be an inherent evolutionarily conserved function in all organisms and have been implicated in the pathophysiology of bipolar disorder. Furthermore, lithium has been shown to regulate circadian cycles in diverse species, including humans, possibly through inhibition of glycogen synthase kinase 3-beta (GSK-3beta), a known target of lithium.


Assuntos
Transtorno Bipolar/genética , Animais , Transtorno Bipolar/tratamento farmacológico , Proteínas Quinases Dependentes de Cálcio-Calmodulina/efeitos dos fármacos , Estimulantes do Sistema Nervoso Central/farmacologia , Ritmo Circadiano/genética , Potenciais Evocados P300 , Predisposição Genética para Doença , Quinase 3 da Glicogênio Sintase , Quinases da Glicogênio Sintase , Humanos , Leucócitos Mononucleares , Lítio/uso terapêutico , Fenótipo , Transdução de Sinais/fisiologia , Privação do Sono
11.
J Clin Psychiatry ; 65(6): 791-804, 2004 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15291656

RESUMO

OBJECTIVE: To examine whether lamotrigine has a unique role in the treatment of bipolar disorder, we evaluated the results of recent clinical trials and molecular and cell biological studies on lamotrigine. DATA SOURCES: Using keywords such as bipolar disorder, lamotrigine, clinical trial, outcomes studies, and mechanisms, we conducted a search for English-language articles on MEDLINE and Index Medicus and also on abstracts presented in recent research conferences. DATA SYNTHESIS: Several studies have strongly suggested that lamotrigine is effective for the acute treatment of bipolar depression as well as for long-term maintenance treatment of bipolar disorder. Stevens-Johnson syndrome is a concern, but the incidence of this side effect may not be as high as previously believed, if dosing is slowly titrated. The action mechanisms underlying the mood-stabilizing effects of lamotrigine are unknown at present but recent studies have produced interesting leads. Lamotrigine modulates various ion channels, altering neuronal excitability. The use-dependent inhibition of neuronal firing by lamotrigine is potentially important because it could result in attenuating supranormal neuronal activities that are possibly associated with bipolar disorder. Lamotrigine inhibits the release of glutamate, similarly to lithium, and its possible association with mood-stabilizing or antidepressant effects needs to be further examined. Unlike lithium or valproic acid, however, lamotrigine does not down-regulate the expression of protein kinase C or MARCKS, suggesting that lamotrigine employs different intracellular mechanisms for long-term changes in neuro-biology from those of lithium or valproic acid. CONCLUSION: The efficacy of lamotrigine for bipolar depression may provide us with new options in the treatment of bipolar disorder. Examining the effects of lamotrigine on various molecular mechanisms in correlation with its unique efficacy on bipolar depression may enhance our understanding of action mechanisms of the mood stabilizers.


Assuntos
Transtorno Bipolar/tratamento farmacológico , Peptídeos e Proteínas de Sinalização Intracelular , Proteínas de Membrana , Triazinas/uso terapêutico , Potenciais de Ação/efeitos dos fármacos , Potenciais de Ação/fisiologia , Afeto/efeitos dos fármacos , Afeto/fisiologia , Transtorno Bipolar/psicologia , Canais de Cálcio/efeitos dos fármacos , Canais de Cálcio/fisiologia , Proteínas de Ligação ao Cálcio , Ensaios Clínicos como Assunto , Ensaios Clínicos Controlados como Assunto , Método Duplo-Cego , Feminino , Glucosidases , Humanos , Lamotrigina , Masculino , Estudos Multicêntricos como Assunto , Substrato Quinase C Rico em Alanina Miristoilada , Fosfoproteínas/efeitos dos fármacos , Fosfoproteínas/fisiologia , Ensaios Clínicos Controlados Aleatórios como Assunto , Transdução de Sinais/efeitos dos fármacos , Transdução de Sinais/fisiologia , Canais de Sódio/efeitos dos fármacos , Canais de Sódio/fisiologia , Transmissão Sináptica/efeitos dos fármacos , Transmissão Sináptica/fisiologia , Resultado do Tratamento , Triazinas/farmacocinética , Triazinas/farmacologia
12.
Brain Res ; 934(1): 69-80, 2002 Apr 26.
Artigo em Inglês | MEDLINE | ID: mdl-11937071

RESUMO

Valproic acid (VPA) is a broad-spectrum anticonvulsant with well-documented teratogenic effects, but whose mechanism of action is largely unknown. In the present study we have examined the effects of VPA on the expression of two prominent substrates for protein kinase C (PKC) in the brain, MARCKS and GAP-43, which have been implicated in actin-membrane plasticity and neurite outgrowth during neuronal differentiation, respectively, and are essential to normal brain development. Immortalized hippocampal HN33 cells exposed to VPA exhibited reduced MARCKS protein expression and demonstrated increased GAP-43 protein expression, with concomitant alterations in cellular morphology, including an increase in the number and length of neurites and accompanied by a reduction in cell growth rate. The effects of VPA were observed at clinically relevant concentrations following chronic (>1 day) VPA exposure. We also present evidence for a VPA-induced alteration in PKC activity, as well as temporal changes in individual PKC isozyme expression. Inhibition of PKC with the PKC-selective inhibitor, LY333531, prevented the VPA-induced down-regulation of membrane-associated MARCKS, but had no effect on the cytosolic MARCKS reduction or the GAP-43 up-regulation. Inhibition of PKC by LY333531 enhanced the differentiating effects of VPA; additionally, LY333531 alone induced greater neurite outgrowth in this cell line. Collectively, these data indicate that VPA induces neuronal differentiation, associated with a reduction in MARCKS expression and an increase in GAP-43 expression, consistent with the hypothesis that a reduction in MARCKS at the membrane may be permissive for cytoskeletal plasticity during neurite outgrowth.


Assuntos
Anticonvulsivantes/farmacologia , Encéfalo/efeitos dos fármacos , Diferenciação Celular/efeitos dos fármacos , Peptídeos e Proteínas de Sinalização Intracelular , Proteínas de Membrana , Plasticidade Neuronal/efeitos dos fármacos , Neurônios/efeitos dos fármacos , Proteína Quinase C/efeitos dos fármacos , Ácido Valproico/farmacologia , Animais , Encéfalo/embriologia , Encéfalo/enzimologia , Diferenciação Celular/fisiologia , Divisão Celular/efeitos dos fármacos , Divisão Celular/fisiologia , Linhagem Celular Transformada , Citoesqueleto/efeitos dos fármacos , Citoesqueleto/enzimologia , Regulação para Baixo/efeitos dos fármacos , Regulação para Baixo/fisiologia , Inibidores Enzimáticos/farmacologia , Feminino , Proteína GAP-43/efeitos dos fármacos , Proteína GAP-43/metabolismo , Hipocampo/citologia , Hipocampo/efeitos dos fármacos , Hipocampo/enzimologia , Humanos , Indóis/farmacologia , Isoenzimas/efeitos dos fármacos , Isoenzimas/metabolismo , Maleimidas/farmacologia , Camundongos , Substrato Quinase C Rico em Alanina Miristoilada , Malformações do Sistema Nervoso/induzido quimicamente , Malformações do Sistema Nervoso/enzimologia , Malformações do Sistema Nervoso/fisiopatologia , Neuritos/efeitos dos fármacos , Neuritos/enzimologia , Neuritos/ultraestrutura , Plasticidade Neuronal/fisiologia , Neurônios/enzimologia , Gravidez , Proteína Quinase C/metabolismo , Proteínas/efeitos dos fármacos , Proteínas/metabolismo , Teratogênicos/farmacologia
13.
Brain Res ; 950(1-2): 52-63, 2002 Sep 20.
Artigo em Inglês | MEDLINE | ID: mdl-12231228

RESUMO

Neonatal maternal separation of rat pups leads to a stable stress hyper-responsive phenotype characterized by increased basal levels of corticotropin releasing factor (CRF) mRNA in the hypothalamic and extra-hypothalamic nuclei, increased hypothalamic CRF release, and enhanced adrenocorticotrophin hormone (ACTH) and corticosterone (CORT) responses to psychological stressors. Stress and exposure to glucocorticoids either early in life or in adulthood have been associated with hippocampal atrophy and impairments in learning and memory. In this study, male Long Evans rat pups were exposed to daily 3-h (HMS180) or 15-min (HMS15) periods of maternal separation on postnatal days (PND) 2-14 or normal animal facility rearing. Maternal separation and subsequent reunion with the dam resulted in elevated plasma CORT levels versus HMS15 animals at PND7, a time when rat pups are normally hyporesponsive to stressors and show limited pituitary-adrenal responses. As adults, HMS180 rats exhibited elevated indices of anxiety, startle-induced pituitary-adrenal hyper-responsiveness, and slight, but significant impairment on acquisition in the Morris water maze task. In addition, HMS180 rats exhibited decreased mossy fiber density in the stratum oriens region of the hippocampus as measured by Timm's staining, but no change in volume of the dentate gyrus. These changes may be the result of neonatal exposure to elevated glucocorticoids and/or changes in other signaling systems in response to maternal separation. Overall the results suggest that repeated, daily, 3-h maternal separations during critical periods of hippocampal development can disrupt hippocampal cytoarchitecture in a stable manner. The resulting change in morphology may contribute to the subtle, but consistent learning deficit and overall stress hyper-responsive phenotype observed in these animals.


Assuntos
Privação Materna , Fibras Musgosas Hipocampais/patologia , Estresse Fisiológico/patologia , Hormônio Adrenocorticotrópico/biossíntese , Hormônio Adrenocorticotrópico/sangue , Animais , Animais Recém-Nascidos , Corticosterona/sangue , Feminino , Masculino , Aprendizagem em Labirinto/fisiologia , Gravidez , Ratos , Ratos Long-Evans , Estresse Fisiológico/metabolismo
14.
Neurosci Lett ; 368(3): 293-6, 2004 Sep 30.
Artigo em Inglês | MEDLINE | ID: mdl-15364414

RESUMO

Protein kinase C gamma (PKC gamma) is highly expressed in the rodent hippocampus and has been implicated in long-term alterations in synaptic efficacy. Acute stress has been shown to negatively affect hippocampal synaptic plasticity, and the present study examined the effect of acute stress on PKC gamma expression/subcellular distribution by quantitative western blotting in two inbred mouse strains (C57BL/6J versus DBA/2J) with established differences in hippocampal plasticity. It was found that both DBA/2J and C57BL/6J strains exhibited similar basal, stress-induced elevations, and recovery of serum corticosterone levels. Acute stress produced a significant reduction in both membrane and cytosolic PKC gamma expression in the hippocampus of C57BL/6J mice compared to no-stress controls, but did not alter either membrane or cytosolic PKC gamma expression in the hippocampus of DBA/2J mice compared to no-stress controls. These data provide direct evidence that PKC gamma is differentially regulated in the hippocampus of C57BL/6J and DBA/2J mice by acute stress. The role of stress-induced regulation of hippocampal PKC gamma expression in hippocampal synaptic plasticity is discussed.


Assuntos
Hipocampo/enzimologia , Proteína Quinase C/antagonistas & inibidores , Estresse Fisiológico/enzimologia , Animais , Isoenzimas/antagonistas & inibidores , Isoenzimas/biossíntese , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos DBA , Proteína Quinase C/biossíntese , Restrição Física , Especificidade da Espécie , Estresse Fisiológico/genética
16.
J Bronchology Interv Pulmonol ; 19(1): 61-4, 2012 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-23207267

RESUMO

SUMMARY: : Diffuse pulmonary ossification is a rare clinical entity in which mature bone formation occurs within the pulmonary tissues. It has been associated with multiple pulmonary and systemic conditions and may be an indicator of disease severity and chronicity. It is often diagnosed only post mortem, because of its variable presentation with either very significant findings, mimicking other serious conditions, or very subtle onset unrecognized on imaging. In this report, we present the clinical presentation and findings in a case of diffuse pulmonary ossification diagnosed by transbronchial biopsy in a living patient.


Assuntos
Doenças Pulmonares Intersticiais/patologia , Pulmão/patologia , Ossificação Heterotópica/patologia , Fibrose Pulmonar/patologia , Idoso , Biópsia , Dispneia/etiologia , Humanos , Doenças Pulmonares Intersticiais/complicações , Masculino , Ossificação Heterotópica/etiologia , Fibrose Pulmonar/complicações , Fibrose Pulmonar/diagnóstico por imagem , Radiografia
17.
Heart Lung ; 41(6): e18-20, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22652168

RESUMO

Octreotide is a somatostatin analogue used to control upper gastrointestinal bleeding. We report a case of a patient with no significant cardiac history who had multiple asystolic events during an octreotide infusion at a relatively low dose. Although octreotide leading to bradycardia and heart block has been documented in several case reports, to our knowledge, octreotide-associated asystole has not been described. It is pertinent that physicians must be aware of this significant cardiac effect for vigilant cardiac monitoring and management, preferably in an intensive care setting. Furthermore, this suggests that although dose- and route-related effects have been described, some individuals may be susceptible at low doses, even in the absence of heart disease. There were no further recurrences after the drug was discontinued.


Assuntos
Eletrocardiografia , Hemorragia Gastrointestinal/tratamento farmacológico , Parada Cardíaca/induzido quimicamente , Octreotida/efeitos adversos , Idoso , Feminino , Fármacos Gastrointestinais/administração & dosagem , Fármacos Gastrointestinais/efeitos adversos , Parada Cardíaca/fisiopatologia , Humanos , Infusões Intravenosas , Unidades de Terapia Intensiva , Octreotida/administração & dosagem
20.
J Clin Oncol ; 28(2): 202-6, 2010 Jan 10.
Artigo em Inglês | MEDLINE | ID: mdl-19933904

RESUMO

PURPOSE: The optimal treatment for medically inoperable stage I non-small-cell lung cancer (NSCLC) has not been defined. PATIENTS AND METHODS: Cancer and Leukemia Group B trial 39904 prospectively assessed accelerated, once-daily, three-dimensional radiotherapy for early-stage NSCLC. The primary objectives were to define the maximally accelerated course of conformal radiotherapy and to describe the short-term and long-term toxicity of therapy. Entry was limited to patients with clinical stage T1N0 or T2N0 NSCLC (< 4 cm) and pulmonary dysfunction. The nominal total radiotherapy dose remained at 70 Gy, while the number of daily fractions in each successive cohort was reduced. RESULTS: Thirty-nine eligible patients were accrued (eight patients each on cohorts 1 to 4 and seven patients on cohort 5) between January 2001 and July 2005. One grade 3 nonhematologic toxicity was observed in both cohort 3 (dyspnea) and cohort 4 (pain). The major response rate was 77%. After a median follow-up time of 53 months, the actuarial median survival time of all eligible patients was 38.5 months. Local relapse was observed in three patients. CONCLUSION: Accelerated conformal radiotherapy was well tolerated in a high-risk population with clinical stage I NSCLC. Outcomes are comparable to prospective reports of alternative therapies, including stereotactic body radiation therapy and limited resection, with less apparent severe toxicity. Further investigation of this approach is warranted.


Assuntos
Carcinoma Pulmonar de Células não Pequenas/radioterapia , Pneumopatias/complicações , Neoplasias Pulmonares/radioterapia , Radioterapia Conformacional/métodos , Idoso , Idoso de 80 Anos ou mais , Carcinoma Pulmonar de Células não Pequenas/complicações , Intervalo Livre de Doença , Feminino , Humanos , Neoplasias Pulmonares/complicações , Masculino , Pessoa de Meia-Idade , Dosagem Radioterapêutica
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA